The report found top pharmacy benefit managers made more than $7.3 billion by marking up the prices of dozens of generic ...
In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in ...
SEC sues Elon Musk over Twitter purchase, Microsoft says businesses should get quantum ready in 2025, and more news to start ...
Wells Fargo & Co. (NYSE: WFC), Bank of America Corp. (NYSE: BAC) and Truist Financial Corp. (NYSE: TFC) are scheduled to ...
The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug middlemen are marking up the prices of specialty generic drugs dispensed at their ...
The U.S. Federal Trade Commission's merger-busting, antitrust enforcement powers are coming under threat as conservatives ...
As a new research report from Colliers says, the role of retail pharmacies has changed over time, moving far beyond roles as ...
The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...
The practice inflated costs for consumers and insurers on key treatments for cancer, multiple sclerosis, HIV, organ transplants, and other conditions and procedures, the FTC said. The report ...
The markups helped the pharmacy-benefit managers reap $7.3 billion from 2017 to 2022, the FTC found.
The suit accuses the company of falsely advertising rental prices by failing to inform renters of numerous mandatory fees.
Representative Ben Cline (R-VA) says the One Agency Act would house all antitrust authority under the Department of Justice. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback